Unichem Laboratories Limited has informed the Exchange that Unichem Laboratories Limited received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA)
UNICHEMLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Unichem Laboratories has received the Establishment Inspection Report (EIR) from the USFDA for its Roha API facility, which was inspected from June 16 to June 20, 2025. The USFDA has classified the inspection outcome as Voluntary Action Initiated (VAI), which is a benign classification. VAI means the facility is considered to be in an acceptable state of compliance and no further regulatory action is required from the agency. This is the second-best possible outcome after No Action Indicated (NAI) and signals a clean inspection.
Positive for shareholders — the clean VAI classification removes any regulatory overhang on the Roha facility, allowing uninterrupted API supplies to the US market and avoiding potential warning letters or import alerts.